Prevention and Management of Type 2 Diabetes and Metabolic Syndrome in the Time of COVID-19: Should We Add a Cup of Coffee?

Sabina Semiz, Fadila Serdarevic

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Recent evidence shows that COVID-19 patients with existing metabolic disorders, such as diabetes and metabolic syndrome, are exposed to a high risk of morbidity and mortality. At the same time, in order to manage the pandemic, the health authorities around the world are advising people to stay at home. This results in decreased physical activity and an increased consumption of an unhealthy diet, which often leads to an increase in body weight, risk for diabetes, insulin resistance, and metabolic syndrome, and thus, paradoxically, to a high risk of morbidity and mortality due to COVID-19 complications. Here we summarize the evidence demonstrating that the promotion of a healthy life style, including physical activity and a dietary intake of natural polyphenols present in coffee and tea, has the potential to improve the prevention and management of insulin resistance and diabetes in the time of COVID-19 pandemic. Particularly, it would be pertinent to evaluate further the potential positive effects of coffee beverages, rich in natural polyphenols, as an adjuvant therapy for COVID-19, which appear not to be studied sufficiently.

Original languageBritish English
Article number581680
JournalFrontiers in Nutrition
Volume7
DOIs
StatePublished - 6 Oct 2020

Keywords

  • ACE2
  • coffee
  • COVID-19
  • insulin resistance
  • obesity
  • physical activity
  • polyphenols
  • type 2 diabetes

Fingerprint

Dive into the research topics of 'Prevention and Management of Type 2 Diabetes and Metabolic Syndrome in the Time of COVID-19: Should We Add a Cup of Coffee?'. Together they form a unique fingerprint.

Cite this